$12.05
7.38% today
Nasdaq, Apr 04, 08:50 pm CET
ISIN
US6412881053
Symbol
NPCE

NeuroPace Inc Stock price

$13.01
+1.20 10.16% 1M
+6.06 87.19% 6M
+1.82 16.26% YTD
+0.64 5.17% 1Y
+4.31 49.54% 3Y
-3.99 23.47% 5Y
-3.99 23.47% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.53 3.91%
ISIN
US6412881053
Symbol
NPCE
Sector

Key metrics

Market capitalization $423.61m
Enterprise Value $444.19m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 5.56
P/S ratio (TTM) P/S ratio 5.30
P/B ratio (TTM) P/B ratio 48.94
Revenue growth (TTM) Revenue growth 22.14%
Revenue (TTM) Revenue $79.91m
EBIT (operating result TTM) EBIT $-21.67m
Free Cash Flow (TTM) Free Cash Flow $-18.26m
Cash position $52.76m
EPS (TTM) EPS $-0.94
P/E forward negative
P/S forward 4.51
EV/Sales forward 4.73
Short interest 1.78%
Show more

Is NeuroPace Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

NeuroPace Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a NeuroPace Inc forecast:

7x Buy
100%

Analyst Opinions

7 Analysts have issued a NeuroPace Inc forecast:

Buy
100%

Financial data from NeuroPace Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
80 80
22% 22%
100%
- Direct Costs 21 21
20% 20%
26%
59 59
23% 23%
74%
- Selling and Administrative Expenses 53 53
0% 0%
66%
- Research and Development Expense 24 24
14% 14%
30%
-17 -17
32% 32%
-22%
- Depreciation and Amortization 4.41 4.41
174% 174%
6%
EBIT (Operating Income) EBIT -22 -22
20% 20%
-27%
Net Profit -27 -27
18% 18%
-34%

In millions USD.

Don't miss a Thing! We will send you all news about NeuroPace Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

NeuroPace Inc Stock News

Neutral
GlobeNewsWire
one day ago
MOUNTAIN VIEW, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, will be attending and presenting at the upcoming American Academy of Neurology (AAN) 2025 Annual Meeting, which is being held in San Diego from April 5 – 9.
Neutral
GlobeNewsWire
2 days ago
-- Beginning of Wind Down of Stereo EEG (SEEG) Distribution Relationship in Q4 2025 -- -- Maintaining 2025 Revenue Guidance -- -- No Change to Long-Range Plan Expectations of Cash Flow Breakeven by the end of 2027 and Achievement of 20%+ Revenue CAGR -- MOUNTAIN VIEW, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the ...
Neutral
GlobeNewsWire
9 days ago
MOUNTAIN VIEW, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the 24th Annual Needham Virtual Healthcare Conference at 3:00pm ET (12:00pm PT) on Tuesday, April 8, 2025.
More NeuroPace Inc News

Company Profile

NeuroPace, Inc. develops, manufactures and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's product RNS system is designed for the treatment of medically refractory partial epilepsy includes implantable and external products. The company was founded by Robert Fischell, David Fischell, Tim Fischell, Scott Fischell, Rebecca L. Kuhn, Frank M. Fischer and Martha Morrell on November 19, 1997 and is headquartered in Mountain View, CA.

Head office United States
CEO Joel Becker
Employees 184
Founded 1997
Website www.neuropace.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today